
Results 1 - 20 of 231 in Enbrel, Etanercept (generic)
Survey shows majority of rheumatologists would prescribe Actemra drug for rheumatoid arthritis
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010. Comment?
Decision Resources: Biosimilars may cause biotech companies to lose more than $9 billion
WALTHAM,A Mass. Biotech companies that manufacture a class of drugs used to treat autoimmune disorders stand to lose more than $9 billion in Europe and the United States by 2018 thanks to competition from biosimilars, according to a report. Comment?
Arthritis Drugs Unlikely to Increase Cancer Risk
w/Photo
Rheumatoid arthritis patients who start taking anti-tumor necrosis factor I drugs are not likely to have a higher risk of developing cancer than other groups of RA patients, according to a Swedish study in the November issue of Arthritis & Rheumatism . Comment?
TNF-alpha inhibitors ranked top for reducing biologics spend
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor -alpha inhibitors stand to erode $9.6 billion in brand sales in the U.S. and Europe by 2018. Comment?
Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel,...
Tumor Necrosis Factor Blockers August 2009 August 31, 2009 Audience: Rheumatologists, gastroenterologists, oncologists, dermatologists [UPDATED 08/31/2009] Supplemental Q&As added [Posted 08/04/2009] FDA notified healthcare professionals that it has completed its analysis of tumor necrosis factor blockers and has concluded that there is an ... Comment?
TNF Blockers Do Not Increase Cancer Risk in Rheumatoid Arthritis Patients
A Swedish study has concluded that rheumatoid arthritis patients did not experience an increased cancer risk in the first 6 years of treatment with TNF blockers . Comment?
Study Eases Arthritis Drug Cancer Fears
Oct. 29, 2009 -- Rheumatoid arthritis patients who take the biologic drugs Remicade , Humira , and Enbrel do not appear to have an increased risk for developing cancer in the first few years of use, researchers in Sweden report. Comment?
Rheumatoid Arthritis Treatment Doesn't Promote Cancer
w/Photo
Treatment with tumor necrosis factor blockers doesn't increase rheumatoid arthritis patients' risk of cancer, new research has found. Comment?
Study Eases Arthritis Drug Cancer Fears
Oct. 29, 2009 - Rheumatoid arthritis patients who take the biologic drugs Remicade , Humira, and Enbrel do not appear to have an increased risk for developing cancer in the first few years of use, researchers in Sweden report. Comment?
Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In RAPpatients
A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor therapy. Comment?
Watching insiders is like participating in a weeks-long stakeout. You expect something to happen, but you don't know what. Comment?
Weighing Pain Relief and Cancer Risk
During the past decade, a new class of drugs, called TNF inhibitors, has improved the lives of tens of thousands of people who suffer from painful autoimmune diseases including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. Comment?
Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In ...
A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor therapy. Comment?
Can curry spice soothe psoriasis?
Back in the dim days of black-and-white television, one over-the-counter product that was frequently advertised claimed to help "the heartbreak of psoriasis." The phrase is no longer heard in commercials, but the heartbreak is still there. Comment?
Cephalon Signs Option Agreement To Acquire BioAssets Development ...
Cephalon, Inc. and BioAssets Development Corporation , a privately held biopharmaceutical company, today announced that the companies have signed an agreement that will provide Cephalon with an option to acquire BDC. Comment?
Im getting ready to start Enbrel. Does anyone have comments or suggestions Tom Ensley is getting ready for some changes!! Living With It hello,i am 36. Comment?
Sustaining Operational Excellence Improvements
Last week, Pfizer, the world's largest biopharmaceutical company, officially completed its merger with Wyeth, which produces some of the world's top-selling medicines, including Enbrel for rheumatoid arthritis and Prevnar, a vaccine against pneumococcal disease. Comment?
Revolutionary New Treatment for Sciatica Advances in the Clinic
Chemical inflammation of spinal nerve roots is a major factor in sciatic pain. Chronic and severe sciatica causes widespread disability, and represents a significant unmet medical need. Comment?
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors will drive the psoriasis drug market to increase from $3 billion in 2008 to $5.2 billion in 2018 in the United States, France, ... Comment?
Cephalon Signs Option To Acquire BioAssets
Cephalon, Inc. and BioAssets Development Corp. have signed an agreement that will provide Cephalon with an option to acquire BDC. Comment?